Mycotopia Therapies, Inc.

Equities

TPIA

US62846W1071

Market Closed - OTC Markets Other stock markets 03:13:05 2024-04-23 pm EDT			5-day change	1st Jan Change
0.058 ^USD	+29.00%		-23.75%	+263.12%

Apr. 23	Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Mycotopia Therapies Inc. Appoints Dr. Saphire Longmore as Chief Medical Officer of Caribbean Affairs

November 10, 2021 at 08:30 am EST

Mycotopia Therapies Inc. announced the appointment of Saphire Longmore M.B.B.S., DM, to the role of Chief Medical Officer of Caribbean Affairs.

Latest news about Mycotopia Therapies, Inc.

Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 23	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-14	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.	23-02-15	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	22-05-23	CI
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market	22-05-02	CI
Mycotopia Therapies Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-14	CI
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt	22-04-13	CI
Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc	22-03-17	CI
Ei.Ventures, Inc. entered into a letter of interest to acquire Mycotopia Therapies Inc. in a reverse merger transaction for $360 million.	21-12-06	CI
Mycotopia Therapies and Agile Pharmaceutical Solutions Plan to Conduct Oversight and Development of the Tablet in Jamaica and Explore the Possibility of Partnering with Havn Life Sciences in Jamaica	21-11-17	CI
Mycotopia Therapies Inc. Appoints Dr. Saphire Longmore as Chief Medical Officer of Caribbean Affairs	21-11-10	CI
Mycotopia Therapies Inc. has Changed its Ticker to MYCO from TPIA	21-05-03	CI
20/20 Global, Inc. Announces Management Resignations	21-03-30	CI
Mycotopia Therapies (20/20 Global, Inc.) Announces Joint Venture with Biomedican to Establish Biosynthetic Compound Subsidiary Known as PsyBioMed	21-02-08	CI
Mycotopia Therapies Inc. completed the acquisition of 20/20 Global, Inc. in a reverse merger transaction.	21-01-18	CI
Mycotopia Therapies agreed to acquire 20/20 Global, Inc. for $0.35 million in a reverse merger transaction.	20-12-27	CI

Chart Mycotopia Therapies, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data